Literature DB >> 16165160

Detecting psychotic major depression using psychiatric rating scales.

Jennifer Keller1, Rowena G Gomez, Heather A Kenna, Joel Poesner, Charles DeBattista, Benjamin Flores, Alan F Schatzberg.   

Abstract

OBJECTIVE: The aim of this study was to assess whether individual or clusters of psychiatric symptoms can differentiate patients with psychotic major depression (PMD) from those with nonpsychotic depression (NPMD).
METHOD: Data were pooled from two studies investigating patients with moderate depression. A total of 129 subjects were studied. Patients in Sample 1 were unmedicated, while the majority of the patients in Sample 2 were taking psychotropic medications. Baseline rating scales were obtained for all subjects, including the Hamilton depression rating scale and the brief psychiatric rating scale (BPRS). We used discriminant function analyses, logistic regression, and ROC analyses to determine the patterns in symptoms that differentiated the groups.
RESULTS: Psychotic patients were adequately differentiated by the unusual thought content (UTC) item of the BPRS. Even mild UTC endorsement was an indicator of PMD. Furthermore, results suggest that the positive symptom subscale of the BPRS was even better at differentiating PMD from NMPD patients. Sensitivity and specificity for this scale were 84% and 99%, respectively.
CONCLUSION: Psychotic major depression is often undiagnosed and poorly treated. One reason for this trend is the failure of physicians to inquire in a more detailed manner about positive symptoms in patients with primary mood symptoms. Although physicians are not likely to have the time to conduct an entire BPRS during an evaluation, our results suggest that a few key symptoms, if assessed directly, may aid the psychiatrist to more effectively diagnose and subsequently treat their depressed patients.

Entities:  

Mesh:

Year:  2005        PMID: 16165160     DOI: 10.1016/j.jpsychires.2005.07.003

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  7 in total

1.  Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression.

Authors:  Ryan Kelley; Amy Garrett; Jeremy Cohen; Rowena Gomez; Anna Lembke; Jennifer Keller; Allan L Reiss; Alan Schatzberg
Journal:  Psychiatry Res       Date:  2012-11-11       Impact factor: 3.222

Review 2.  Rating scales measuring the severity of psychotic depression.

Authors:  S D Østergaard; A J Rothschild; A J Flint; B H Mulsant; E M Whyte; A K Leadholm; P Bech; B S Meyers
Journal:  Acta Psychiatr Scand       Date:  2015-05-27       Impact factor: 6.392

3.  Increased plasma norepinephrine concentration in psychotic depression.

Authors:  Jaap G Goekoop; Remco F P de Winter; Ron Wolterbeek; Godfried M J Van Kempen; Victor M Wiegant
Journal:  Ther Adv Psychopharmacol       Date:  2012-04

Review 4.  Current issues in the classification of psychotic major depression.

Authors:  Jennifer Keller; Alan F Schatzberg; Mario Maj
Journal:  Schizophr Bull       Date:  2007-06-04       Impact factor: 9.306

5.  Distinctive Clinical Correlates of Psychotic Major Depression: The CRESCEND Study.

Authors:  Seon-Cheol Park; Hwa-Young Lee; Jeong-Kyu Sakong; Tae-Youn Jun; Min-Soo Lee; Jae-Min Kim; Jung-Bum Kim; Hyeon-Woo Yim; Yong Chon Park
Journal:  Psychiatry Investig       Date:  2014-07-21       Impact factor: 2.505

6.  Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression.

Authors:  Thaddeus Block; Georgios Petrides; Harvey Kushner; Ned Kalin; Joseph Belanoff; Alan Schatzberg
Journal:  J Clin Psychopharmacol       Date:  2017-10       Impact factor: 3.153

7.  The experience of admission to psychiatric hospital among Chinese adult patients in Hong Kong.

Authors:  Jackie Chi-Kin Fu; Paulina Po-Ling Chow; Linda Chiu-Wa Lam
Journal:  BMC Psychiatry       Date:  2008-10-17       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.